JAAD Case Reports (Jun 2022)

Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis

  • Eleanor Pope, BA,
  • Eric Kowalski, MD,
  • Francisco Tausk, MD

Journal volume & issue
Vol. 24
pp. 59 – 60

Abstract

Read online

No abstracts available.

Keywords